• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Astragalus polysaccharide enhances immunity and inhibits H9N2 avian influenza virus in vitro and in vivo

tetano

Editor, Senior Moderator
J Anim Sci Biotechnol. 2013 Jun 21;4(1):22. [Epub ahead of print]
Astragalus polysaccharide enhances immunity and inhibits H9N2 avian influenza virus in vitro and in vivo.
Kallon S, Li X, Ji J, Xi Q, Ma J, Xie Q, Zhang Y.
Abstract

This study investigated the humoral immunization of Astragalus polysaccharide (APS) against the infection of H9N2 avian influenza virus (H9N2 AIV) in chickens.The effects of APS treatment on H9N2 infection were investigated by MTT [3(4, 5-dimethylthiazol-2-yl)-2, 3-diphenyl tetrazolium bromide] assay and analysis of MHC and cytokines mRNA expression. The in vivo effects on lymphocytes and serum antibody titers were also investigated. The IL-4, IL-6, IL-10, LITAF, IL-12 and antibody titers to H9N2 AIV were enhanced in the first week after APS treatment. The results indicated that APS treatment reduces H9N2 AIV replication and promote early humoral immune responses in young chickens.

PMID:
23786718
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23786718
 
Back
Top Bottom